BioCentury
ARTICLE | Company News

VeroScience's Cycloset approved for diabetes

May 7, 2009 1:18 AM UTC

FDA approved an NDA from VeroScience LLC (Tiverton, R.I.) for Cycloset bromocriptine timed-release tablets to treat Type II diabetes. S2 Therapeutics Inc. (Bristol, Tenn.) has worldwide marketing righ...